Overview

Minimal Optimal Dose of Sugammadex in Elective Surgery

Status:
Completed
Trial end date:
2018-09-30
Target enrollment:
Participant gender:
Summary
Time of appearance of TOF Ratio >0,9 with different doses of Sugammadex
Phase:
Phase 4
Details
Lead Sponsor:
Erasme University Hospital